Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Synthesis Institute is a private psychedelic education, retreat, and practitioner-training company operating in the mental health and wellness space. The organization is best known for professionally guided legal psychedelic retreats in the Netherlands and for its Psychedelic Practitioner Core Training program for aspiring facilitators and practitioners. Historically, Synthesis experienced a high-profile operational and bankruptcy-related collapse in parts of its earlier business in 2023, particularly around its Oregon expansion, but its training business later continued under new leadership. The current website presents The Synthesis Institute as a daughter company of The Resurgence Training Institute Inc. and markets active education, events, and retreat offerings. It is not a traditional biotech or pharma drug developer and does not appear to have a conventional therapeutic product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Synthesis Institute.